Therabron Therapeutics Secures New Orphan Designation for the Prevention of Bronchopulmonary Dysplasia
ROCKVILLE, MD — May 13, 2015 — Therabron Therapeutics, Inc. (Therabron), a specialty biotechnology company focused on the advancement of respiratory therapeutics with disease-modifying potential, today announced that the European […]